GSK U.S., part of global healthcare giant GlaxoSmithKline, has announced a ten-year, $10 million commitment in support of a program aimed at helping Black, Latinx, and female students in Philadelphia pursue careers in STEM subjects.
Using a collective impact approach, the Philadelphia STEM Equity Collective will work with out-of-school-time providers, institutions of higher education, employers, local government, and the philanthropic community to identify and close gaps affecting children and youth from groups that are underrepresented in STEM fields. In partnership with the Philadelphia Education Fund, GSK will award grants totaling $1 million annually to local nonprofits. The initial grant recipient, Equal Measure, will use the funds to develop a shared measurement system that tracks outcomes and informs future activities.
"At GSK, we believe that diversity helps to propel the innovation that can make our world better. But we know that for far too long, too many challenges have stood in the way of true inclusion of people of color and women in STEM careers," said Maya Martinez-Davis, GSK's president of US Pharmaceuticals. "The mission of the Philadelphia STEM Equity Collective is to overcome those challenges to benefit the children of Philadelphia, where GSK's legacy spans nearly two centuries."